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Breast cancer is a major public health problem in Western coun-
tries, not withstanding the progress made in the treatment of the
disease (Cole and Rodu, 1996). Prevention of disease would be
preferable, but of the more than 20 risk factors identified for the
disease (Adami et al, 1998) only one is modifiable and associated
with a substantial risk gradient: alcohol consumption (50 g of
ethanol or five drinks per day) increases the risk by about 40%
(Smith-Warner et al, 1998). Because there is an exposure response
trend for most factors that have been shown to increase the risk of
cancer, it would be reasonable to assume that very heavy alcohol
consumption (> 60 g of ethanol or more than six drinks per day)
would further increase the risk of breast cancer. Somewhat surpris-
ingly, several studies (Hiatt and Bawol, 1984; Lê et al, 1984;
Longnecker et al; 1995a; 1995b; Thun et al, 1997), as well as a
pooled analysis of cohort studies (Smith-Warner et al, 1998),
showed some evidence of a plateau of breast-cancer risk among
women consuming very large quantities of alcohol. Limited statis-
tical power and concern about misclassification of alcohol intake,
however, hampered further interpretation (Smith-Warner et al,
1998). In order to adequately investigate how extreme levels of
alcohol intake affect breast-cancer risk, we have undertaken a
population-based cohort study in Sweden, utilizing nationwide
registry data. The present study is the largest study of breast-
cancer risk among female alcoholics ever to be carried out (Prior,
1988; Adami et al, 1992; Tonnesen et al, 1994; Sigvardsson et al,
1996).
MATERIALS AND METHODS
In Sweden there is virtually no private inpatient treatment.
Hospital-provided medical services are population-based and
referable to the county in which the patient lives. From 1965
onwards, the National Board of Health and Welfare started
collecting data on individual hospital discharges in the Inpatient
Register. From 1987, the register attained complete nationwide
coverage. All patients recorded in the Inpatient Register with a
discharge diagnosis of alcoholism were initially selected for inclu-
sion in the study. A total of 196 803 individually unique national
registration numbers, assigned to all Swedish residents, were
registered at least once with a diagnosis of alcoholism between
1965 and 1994. December 31, 1995 was the end of the observation
period.
Record linkage of the study cohort to the nationwide Registers
of Causes of Death, Emigration and Cancer allowed the calcula-
tion of follow-up time, in person-years, of eligible persons at risk
as described previously in detail (Adami et al, 1992; 1996). From
the total cohort 7790 records were excluded because of erroneous
or incomplete national registration numbers, a further 3405
patients were excluded because they had prevalent cancers at the
time observation began and another 2941 patients because of
inconsistencies uncovered during record linkage. Thus a total of
182 667 patients with alcoholism remained eligible, and of these
36 856 were women.
The expected number of cancers was calculated by multiplying
the number of observed person-years by age (in 5-year groups),
sex, and calendar year-specific cancer incidence rates of first
breast cancers. These rates, derived from the entire Swedish popu-
lation and aggregated by 5 calendar years to avoid instability, were
calculated by dividing the number of first breast cancers,
excluding those discovered incidentally at autopsy, by person-
years at risk (number of mid-year population without a previously
reported cancer diagnosis). The main outcome, the standardized
incidence ratio (SIR), was calculated as the ratio of the observed
number of cancers to that expected. The 95% confidence interval
(CI) of the SIR was calculated on the basis of the Poisson distribu-
tion. In main analyses, we excluded cancers and person-years
accumulated during the first year of follow-up in order to
minimize the possible impact of selection and detection biases
(Berkson, 1946).
As the studied potential determinants of breast-cancer risk,
including certain diseases among the alcoholic women, may co-
vary and thus confound each other, we modelled breast-cancer risk
in relation to age at follow-up, duration of follow-up, calendar
year at enrolment to the cohort, and presence of diabetes or liver
cirrhosis, using Poisson regression by taking the expected number
of cases in the offset.
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The mean age at entry for the 36 856 women with a diagnosis of
alcoholism in the study was 42.7 years, and the mean duration of
follow-up was 9.6 years, yielding a total of 353 596 woman-years
at risk. Among these women 2352 (6.4%) also had a diagnosis of
liver cirrhosis in at least one hospitalization before the diagnosis of
breast cancer; the corresponding figure for diabetes mellitus was
2003 (5.4%). The mean calendar year at enrolment was 1983.
The results based on external comparisons are summarized in
Table 1. We found a statistically significant overall excess risk of
breast cancer among women with a previous diagnosis of alco-
holism. The excess, however, is small, amounting to about 15%
over the age-adjusted average risk among Swedish women. We
found no evidence for an important variation in risk over 1–30
years of follow-up, nor any difference with age at diagnosis of
breast cancer or with menopausal status, using age 50 to crudely
separate the pre- and post-menopausal women.
Results based on internal comparisons within the cohort of alco-
holics and generated by Poisson regression are shown in Table 2.
Notwithstanding mutual adjustment, we found no convincing
trends with age at follow-up, duration of follow-up or calendar
year of entry, the latter used as a marker of changes in diagnostic
practices. Neither diabetes nor liver cirrhosis appeared to be
significantly related to risk and any associations may be due to
chance.
DISCUSSION
Alcoholic women are characterized by elevated serum levels of
oestradiol (Gavaler and van Thiel, 1992). Post-menopausal alco-
holic women with cirrhosis have, in addition, low levels of testos-
terone, follicle stimulating hormone and luteinizing hormone
(Gavaler and van Thiel, 1992). Moreover, among alcoholic
women there appears to be a derangement of the usual pattern of
association among the various hormones, indicating a disruption
of the normal feedback mechanisms (Gavaler and van Thiel,
1992). Both alcohol intake and elevation of oestrogen levels would
argue for a substantial increase in breast-cancer risk, but instead
the increase in risk observed in our study was fairly small.
Because our study used a cohort design and a nationwide source
population with virtually complete follow-up, we consider selec-
tion and information bias unlikely, especially since the first year of
follow-up was excluded. It is possible, but not well substantiated,
that women who are alcoholics compared to the background
population have an earlier age at first full-term pregnancy, more
pregnancies, and – as a consequence of their higher smoking
prevalence – an earlier menopause, as well as being generally of
lower socioeconomic status. These risk factors are, however, too
weakly associated with breast-cancer risk in this Swedish popula-
tion to introduce more than minimal underestimation of risk
(Adami et al, 1998). Concerns about confounding by body mass
index – which has a known dual effect on breast-cancer risk
(Adami et al, 1998) – are offset by the similar risks among pre- and
post-menopausal women, and the potential confounding effect of
diabetes mellitus was controlled for in the Poisson analysis
(Weiderpass et al, 1997). Lastly, associations with use of oral
contraceptives and hormone replacement therapy in relation to
breast-cancer risk are weak (Collaborative Group on Hormonal
Factors in Breast Cancer, 1997; 1998) and low use among alco-
holic women has not been demonstrated. A recent study in a
partially overlapping population (Magnusson et al, 1999) and in
other settings (Hiatt and Bawol, 1984; Lê et al, 1984; Longnecker
et al, 1995a) with detailed adjustment for confounding provides
further reassurance that confounding is of limited concern in
studies of alcohol and breast cancer.
As the Swedish Inpatient Register did not contain any indices of
disease severity, we were unable to study dose-response. Attempts
to use number of hospitalizations per unit of time (hospitalization
density) as a proxy for severity had to be given up because of
survival bias; a low hospitalization density presupposed a long
follow-up time, and since censoring occurred at the time of cancer
diagnosis, a long follow-up time followed by a new admission for
alcoholism (and not cancer) was, in practice, without risk for
cancer.
There are several possible explanations for our finding that the
risk for breast cancer does not further increase with very high, as
contrasted to high (~50 g of ethanol per day), alcohol intake. First,
amenorrhoea (Mello et al, 1996) and a breakdown of normal
hormonal feedback mechanisms (Gavaler and van Thiel, 1992)
have been reported to be relatively frequent among alcoholic
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Table 1 Breast cancer incidence between 1966 and 1995 among 36 856
women who were hospitalized for alcoholism at least 1 year prior to the
diagnosis of breast cancer
Determinant Observed cases Standardized 95% confidence
incidence ratio interval
Years of follow-up
1–30* 514 1.15 1.05–1.25
< 1 40 1.09 0.78–1.49
1–9 331 1.21 1.08–1.35
³ 10 183 1.06 0.91–1.22
Age at follow-up* (years)
<50 143 1.11 0.93–1.30
50–59 153 1.16 0.98–1.36
60–69 129 1.14 0.95–1.35
³ 70 89 1.24 0.99–1.52
*Excluding the first year of follow-up
Table 2 Poisson regression-derived relative risk (RR) with 95% confidence
interval (CI) of risk for breast cancer*
Determinant RR 95% CI
Age at follow-up (years)
< 50 1.00 Reference
50–59 1.06 0.84–1.33
60–69 1.07 0.91–1.53
³ 70 1.18 0.91–1.53
Duration of follow-up (years)
1–9 1.00 Reference
³ 10 0.84 0.69–1.02










*Cancers and person-years accrued during the first year of follow-up were
excluded. The baseline standardized incidence ratio for patients with all the
reference characteristics was estimated to be 1.31women, particularly among those with cirrhosis, thus reducing
breast-cancer risk. Secondly, experimental and human data indi-
cate that high levels of oestrogens may down-regulate oestrogen
receptor-a expression (Lawson et al, 1999) that, in turn, limits
expression of oestrogenic effects including breast-cancer progres-
sion. Last, in studies in female rodents, Hilakivi-Clarke (1996) has
noticed that a deficit of oestradiol exposure tends to increase
alcohol consumption. Nevertheless, our data challenge a
monotonic causal association between alcohol and breast cancer.
In conclusion, this study indicates that, contrary to expectation,
alcoholism does not increase breast-cancer risk in proportion 
to presumed ethanol intake. Nevertheless, our findings do not
challenge the existence of a positive association between alcohol
intake and breast-cancer risk, nor do they contradict the exposure–
response pattern reported by other investigators at lower levels of
alcohol intake.
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